Skip to main content

Table 5 Plasma lipids significantly (p < 0.05) associated with baseline ht-TKV. Effect size represents the magnitude and direction (+/−) of association between a given lipid and ht-TKV, estimated by linear regression, while controlling for the selected HALT covariates, age, sex, genotype, site of sample collection, and BMI

From: Plasma metabolites and lipids associate with kidney function and kidney volume in hypertensive ADPKD patients early in the disease course

Lipid Effect Size (SD) p-value FDR q-value
Triglyceride(51:3) [M + K]+ 0.1626 (0.038) < 0.0001 0.0031
Triglyceride(53:3) [M + K]+ 0.1827 (0.055) 0.0010 0.0492
Sphingomyelin(d43:1) [M + H]+ 0.1560 (0.070) 0.0276 0.5728
Triglyceride d5(17:0/17:1/17:0) iSTD [M + Na]+ 0.1038 (0.049) 0.0337 0.5728
Triglyceride(54:5) A [M + K]+ 0.1350 (0.064) 0.0352 0.5728
Triglyceride(52:3) [M + K]+ 0.1719 (0.082) 0.0360 0.5728
  1. bold Q-values indicate signficance, <0.05